Navigation Links
The Wisconsin Heart Hospital Announces Live Webcast Demonstrating Breakthrough Device to Facilitate Beating Heart and Robotic Coronary Revascularization Surgery
Date:1/11/2008

video footage that shows a robotic closed-chest bypass procedure using the C-Port Flex A system in combination with the da Vinci(R) Surgical System. To date, Dr. Brunsting has performed several closed chest procedures using the Cardica device.

Moderating the live procedure will be Tung Cai, M.D., Medical Director and Chief of Cardiothoracic Surgery at the Presbyterian Hospital of Denton. Dr Cai will present his published clinical patency data on the C-Port distal portfolio and review Dr. Balkhy's C-Port patency data from the November 2007 American Heart Association Scientific conference. This data was part of a study co-authored with Samuel Wann, M.D., Chair of the Department of Cardiac and Vascular Medicine at The Wisconsin Heart Hospital.

All three physicians will narrate during the procedure, explaining critical aspects of the surgery, and will answer viewers' e-mail questions submitted live during the event.

"This particular type of bypass is vital to the development of robotic, closed-chest bypass procedures, and therefore proving its efficacy in open-chest procedures is critical," said Dr. Balkhy.

According to Dr. Balkhy, "Cardica's C-Port systems represent a breakthrough in distal anastomotic devices that facilitate and simplify beating heart and robotic CABG procedures. These devices allow surgeons to offer patients less invasive cardiac surgery and may improve outcomes. This live webcast will provide surgeons with a convenient forum for an interactive exchange of questions, ideas and opinions about these revolutionary devices."

"The C-Port Flex A system has the potential to revolutionize the field of cardiothoracic surgery, as it may enable closed-chest, robot-assisted CABG procedures to be more reliably performed without the assistance of cardiopulmonary bypass and cardioplegic arrest of the heart," added Dr. Brunsting.

About The Wisconsin Heart Hospital

Located in Wauwatosa, Wisconsin, The Wisconsin Heart H
'/>"/>

SOURCE The Wisconsin Heart Hospital
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. New Drug Application for Tolvaptan, Otsukas Investigational Novel Oral Treatment for Worsening Heart Failure and Hyponatremia, Accepted by the U.S. Food and Drug Administration
2. Vasogen and Grupo Ferrer Announce Initial Roll-out of Celacade - New Therapy for Chronic Heart Failure
3. New Cardiology Software Helps Heart Centers Manage for Optimal Clinical Performance
4. Berlin Heart Enrolls First Patient in US Multi-Center EXCOR(R) Pediatric VAD IDE Study
5. WorldHeart Schedules Teleconference
6. Patent on Technology for the Delivery of Stem Cells to the Human Heart Issued to CellCyte Genetics Corp. of Washington
7. Presentation of Phase IIa Results for Cytos Biotechnologys Hypertension Vaccine at the American Heart Association Scientific Sessions 2007
8. Reverse Cholesterol Transport by RVX-208 a Small Molecule for ApoA-I Production Increase Presented at American Heart Association Scientific Meeting
9. ALOKA to Introduce New ProSound Diagnostic Ultrasound Systems at the Scientific Session 2007 of American Heart Association, 4th to 7th of November 2007 in Orlando, Florida
10. CV Therapeutics Announces Presentations at American Heart Association Scientific Sessions 2007
11. Americas Heartland Launches Third Season Highlighting Contributions of American Farmers and Ranchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
(Date:12/17/2014)... SOUTH SAN FRANCISCO, Calif. , Dec. 17, ... positive results of a Phase 2 study evaluating ... for the treatment of patients with severe, chronic ... the current standard of care, including topical steroids ... endpoint was percent change in Visual Analog Scale ...
(Date:12/15/2014)...  GlassesOff Inc. (OTCBB: GLSO) announced today the appointment ... director of the Company,s Board of Directors. ... its CEO until its acquisition by Stanley Black ... Recognized as the inventor of the first Wi-Fi-based Active ... -based RFID solutions focused on improving operational efficiency, safety ...
(Date:12/13/2014)... (PRWEB) December 12, 2014 Clarassance, a ... announced its new name: Therabron Therapeutics , Inc. ... and bronchioles (a type of structure in the lungs ... company’s mission to develop novel protein therapeutics for the ... directors decided to change the name to mark the ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2
... positions Company to ... quarter of this year, ROCKVILLE, Md., Sept. 19 ... has completed enrollment of healthy,volunteers in a Phase IIa ... vaccine. The Phase IIa randomized, placebo,controlled clinical trial is ...
... Thirty seven medical,experts in psychiatry from across the ... urgent action to optimize services for people with ... or bipolar,disorder(i)., Professor W. Wolfgang Fleischhacker, principal ... Mental Disorders: Clinical,Policy, and Research Challenges which was ...
... NEP ),today announced that the Company has received ... indicating that the Company is not in,compliance with certain ... the AMEX Company Guide. Specifically, AMEX noted the,Company,s failure ... relating to stockholders, equity of less than $6,000,000 and ...
Cached Biology Technology:Novavax Completes Enrollment of Its Seasonal Influenza VLP Vaccine Phase IIa Clinical Trial 2Novavax Completes Enrollment of Its Seasonal Influenza VLP Vaccine Phase IIa Clinical Trial 3Novavax Completes Enrollment of Its Seasonal Influenza VLP Vaccine Phase IIa Clinical Trial 4Global Psychiatrists Unite to Improve Services in Mental Health 2Global Psychiatrists Unite to Improve Services in Mental Health 3Nephros Receives Non-Compliance Notification from AMEX 2Nephros Receives Non-Compliance Notification from AMEX 3
(Date:11/21/2014)... 2014 C-Labs LLC, a leading provider of ... (IoT), today announced the appointment of John Traynor ... a strategic advisor to the firm, Mr. Traynor will ... is based out of the C-Labs office in ... Chris Muench , Chief Executive Officer. Photo ...
(Date:11/18/2014)... -- The Parenteral Drug Association (PDA) today confirmed that seven ... at least seven more will participate in the upcoming 2014 ... in Washington D.C. , Dec. 2-4. ... from the regulatory agencies in the United States ... effort to help advance the use of metrics in the ...
(Date:11/11/2014)... 11, 2014  Forensicon, Inc., a Chicago ... to announce the promotion of Yaniv Schiff ... Forensics. In Schiff,s new role as Director, he will ... digital forensics examiners and provide leadership within the company,s ... http://photos.prnewswire.com/prnh/20141110/157719 Schiff joined Forensicon ...
Breaking Biology News(10 mins):C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer 2FDA's Janet Woodcock, EMA's Emer Cooke Headline PDA Quality Metrics Conference 2Yaniv Schiff Promoted to Director of Digital Forensics at Forensicon, Inc. 2
... at the Ruhr-Universitt Bochum (RUB) have launched a new ... in promoting neuronal survival. The team of Prof Dr ... Department of Molecular Cell Biology, is looking for new ... Fox Foundation finances this research project with 125,000 US ...
... Discovery Fund (LSDF) today announced $1.1 million in ... and non-profit organizations to foster the translation of ... marketplace. Two of the five new ... invented within Washington-based companies. HeatFlow Technologies (principal investigator ...
... Tech leaders close out 2013 with beneficial ... (NASDAQ: SYMC ), Avago Technologies Limited (NASDAQ: ... ) and Apple Inc. (NASDAQ: AAPL) NXT-ID, Inc. ... Its Newly Formed Advisory Board And Shows First Images of ...
Cached Biology News:Life Sciences Discovery Fund announces R&D grants 2Markets Poised for Healthy 2014 as Biometrics Makes Strides in Technology Sector - Company Strengthens Board with Industry's Top Leaders 2Markets Poised for Healthy 2014 as Biometrics Makes Strides in Technology Sector - Company Strengthens Board with Industry's Top Leaders 3Markets Poised for Healthy 2014 as Biometrics Makes Strides in Technology Sector - Company Strengthens Board with Industry's Top Leaders 4Markets Poised for Healthy 2014 as Biometrics Makes Strides in Technology Sector - Company Strengthens Board with Industry's Top Leaders 5Markets Poised for Healthy 2014 as Biometrics Makes Strides in Technology Sector - Company Strengthens Board with Industry's Top Leaders 6
... 13(S)-HODE-d4 contains 4 deuterium atoms at the 9, ... for use as an internal standard for the ... 13(S)-HODE is produced by incubation of linoleic acid ... shown to inhibit the adhesion of tumor cells ...
...
...
Immunogen: Peptide corresponding to amino acid residues from the N-terminal region of human thyroid hormone receptor, alpha1/alpha2-isotype. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Biology Products: